Mayo Clinic Platform_Accelerate has selected 11 health technology startups for its latest accelerator program.
The 30-week program connects national and international companies with Rochester, Minn.-based Mayo Clinic experts and resources to help develop and validate artificial intelligence-driven healthcare solutions. Participants receive access to de-identified clinical data, mentorship from Mayo Clinic physicians and scientists, and opportunities to engage with investors and industry leaders, according to an Oct. 14 news release.
The cohort includes the following companies:
- Bowhead Health, which is developing a radiogenomics platform that uses imaging to predict genomic mutations and guide personalized treatment.
- Cleancard, which is creating an AI-powered at-home cancer detection test.
- Dart Health, which is embedding engineering teams in hospitals to deploy AI solutions for clinical and operational needs.
- Kanjo Health, which is using AI to deliver earlier, personalized care for children with ADHD and autism.
- Koroid, which is developing an AI platform that predicts clinical demand and automates healthcare logistics.
- MedLink Global, which is advancing AI-driven tools for precision psychiatry.
- MyAtlas Health, which is using AI and wearable data to predict and prevent mental health crises.
- Ordinatrum Health, which is offering AI-powered virtual intensive care unit and data integration solutions.
- Promed AI, which is combining at-home testing and multimodal AI for preventive healthcare.
- RTHM, which is improving diagnosis and treatment for complex chronic illnesses such as long COVID and chronic fatigue syndrome.
- Radical, which is developing a general-purpose AI model for oncology to personalize treatment.
